$0.25
0.0164[7.02%]
Last update: 2:24PM Get Real Time Here
Calidi Biotherapeutics
(AMEX:CLDI)Calidi Biotherapeutics Stock (AMEX:CLDI), Analyst Ratings, Price Targets, Predictions
Calidi Biotherapeutics Inc has a consensus price target of $2, established from looking at the 5 latest analyst ratings. The last 3 analyst ratings were released from Baird, Baird, and HC Wainwright & Co. on May 15, 2024, March 21, 2024, and March 21, 2024. With an average price target of $2.83 between Baird, Baird, and HC Wainwright & Co., there's an implied 1033.33% upside for Calidi Biotherapeutics Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Baird
HC Wainwright & Co.
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Calidi Biotherapeutics
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/15/2024 | Buy Now | 700% | Baird | Joel Beatty | $4.5 → $2 | Maintains | Outperform | Get Alert |
| 03/21/2024 | Buy Now | 1700% | Baird | Joel Beatty | $9 → $4.5 | Maintains | Outperform | Get Alert |
| 03/21/2024 | Buy Now | 700% | HC Wainwright & Co. | Robert Burns | $11 → $2 | Maintains | Buy | Get Alert |
| 11/22/2023 | Buy Now | 4300% | HC Wainwright & Co. | Robert Burns | → $11 | Initiates | → Buy | Get Alert |
| 10/09/2023 | Buy Now | 3500% | Baird | Joel Beatty | → $9 | Initiates | → Outperform | Get Alert |
FAQ
What is the target price for Calidi Biotherapeutics (CLDI)?
The latest price target for Calidi Biotherapeutics (AMEX: CLDI) was reported by Baird on May 15, 2024. The analyst firm set a price target for $2.00 expecting CLDI to rise to within 12 months (a possible 700.00% upside). 5 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Calidi Biotherapeutics (CLDI)?
The latest analyst rating for Calidi Biotherapeutics (AMEX: CLDI) was provided by Baird, and Calidi Biotherapeutics maintained their outperform rating.
When was the last upgrade for Calidi Biotherapeutics (CLDI)?
There is no last upgrade for Calidi Biotherapeutics.
When was the last downgrade for Calidi Biotherapeutics (CLDI)?
There is no last downgrade for Calidi Biotherapeutics.
When is the next analyst rating going to be posted or updated for Calidi Biotherapeutics (CLDI)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Calidi Biotherapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Calidi Biotherapeutics was filed on May 15, 2024 so you should expect the next rating to be made available sometime around May 15, 2025.
Is the Analyst Rating Calidi Biotherapeutics (CLDI) correct?
While ratings are subjective and will change, the latest Calidi Biotherapeutics (CLDI) rating was a maintained with a price target of $4.50 to $2.00. The current price Calidi Biotherapeutics (CLDI) is trading at is $0.25, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.